Published on 6 Oct 2023 on Zacks via Yahoo Finance
Shares of uniQure N.V. QURE were up 11.61% on Oct 5 after the company announced a strategic reorganization to reduce its operating expenses.
The company will discontinue investments in more than half of its research and technology projects, which includes AMT-210 for the treatment of Parkinson’s disease and multiple undisclosed programs.
Consequently, a research lab in Lexington will be closed and the company plans to sublease this space.